The NK cell checkpoint NKG2A maintains expansion capacity of human NK cells

Cancers, Free Full-Text

iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti–PD-1 therapy

Natural killer cells in the lung: potential role in asthma and virus-induced exacerbation?

Effect of mTOR Inhibition with Sirolimus on Natural Killer Cell Reconstitution in Allogeneic Stem Cell Transplantation - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy

Current strategies exploiting NK‐cell therapy to treat haematologic malignancies - Johnson - 2018 - International Journal of Immunogenetics - Wiley Online Library

Chimeric Antigen Receptor-Engineered Natural Killer (CAR NK) Cells in Cancer Treatment; Recent Advances and Future Prospects

NKG2 ligands for immune checkpoint modulator research : Get Quote, RFQ, Price or Buy

Natural Killer Cells Overview Thermo Fisher Scientific - US

PDF) The NK cell checkpoint NKG2A maintains expansion capacity of human NK cells

Natural killer cell epigenetic reprogramming in tumors and potential for cancer immunotherapy

Bispecific Antibody Designed for Targeted NK Cell Activation and Functional Assessment for Biomedical Applications

Intratumoral co‐injection of NK cells and NKG2A‐neutralizing monoclonal antibodies

The Promise of NK Cell Therapeutics